WELL Health Technologies Corp.
WELL.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 703.99M | 671.85M | 621.40M | 574.90M | 520.24M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 703.99M | 671.85M | 621.40M | 574.90M | 520.24M |
| Cost of Revenue | 393.13M | 373.04M | 333.44M | 299.06M | 259.55M |
| Gross Profit | 310.86M | 298.82M | 287.95M | 275.84M | 260.69M |
| SG&A Expenses | 276.13M | 271.47M | 265.03M | 200.36M | 189.30M |
| Depreciation & Amortization | 50.06M | 48.77M | 46.57M | 45.02M | 43.09M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 827.54M | 801.49M | 753.26M | 544.45M | 491.95M |
| Operating Income | 48.20M | 42.12M | 39.89M | 30.45M | 28.29M |
| Income Before Tax | 69.12M | 120.51M | 36.36M | 14.24M | 2.39M |
| Income Tax Expenses | -175.60K | -991.20K | 1.85M | 2.12M | -1.18M |
| Earnings from Continuing Operations | 69.30 | 121.50 | 34.51 | 12.12 | 3.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.55M | -13.89M | -12.84M | -12.25M | -8.95M |
| Net Income | 53.75M | 107.61M | 21.67M | -135.50K | -5.38M |
| EBIT | 48.20M | 42.12M | 39.89M | 30.45M | 28.29M |
| EBITDA | 102.79M | 95.41M | 90.99M | 67.72M | 65.44M |
| EPS Basic | 0.22 | 0.44 | 0.09 | 0.00 | -0.02 |
| Normalized Basic EPS | -0.06 | -0.07 | -0.07 | -0.05 | -0.04 |
| EPS Diluted | 0.25 | 0.47 | 0.13 | -0.01 | -0.03 |
| Normalized Diluted EPS | -0.06 | -0.07 | -0.07 | -0.05 | -0.04 |
| Average Basic Shares Outstanding | 978.39M | 967.69M | 957.07M | 946.11M | 935.31M |
| Average Diluted Shares Outstanding | 994.98M | 984.28M | 957.07M | 946.11M | 935.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
